Haiyan Yang
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- CRISPR and Genetic Engineering 15
-
- COVID-19 Clinical Research Studies 33
- Antimicrobial Resistance in Staphylococcus 13
- Co-authors
- Guangcai Duan (57 shared papers)Shuaiyin Chen (66 shared papers)Yuefei Jin (39 shared papers)Wangquan Ji (18 shared papers)Weidong Wu (1 shared paper)William Zhang (1 shared paper)Yadong Wang (61 shared papers)Guangcai Duan (36 shared papers)
- Journals
- Frontiers in Microbiology (7 papers)Scientific Reports (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Oncotarget (4 papers)The Journal of Infectious Diseases (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Haiyan Yang
207 papers receiving 4.1k citations
Haiyan Yang's Hit Papers
Peers
Comparison fields: 5 of 166
- Infectious Diseases 1.3k
- Molecular Medicine 214
- Neurology 441
- Modeling and Simulation 133
- Endocrinology 132
Countries citing papers authored by Haiyan Yang
This map shows the geographic impact of Haiyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Yang more than expected).
Fields of papers citing papers by Haiyan Yang
This network shows the impact of papers produced by Haiyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Yang. The network helps show where Haiyan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Haiyan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Virology, Epidemiology, Pathogenesis, and Control of COVID-19 Hit paper breakdown → | 2020 | 1079 |
| 2 | 2020 | 292 | |
| 3 | 2019 | 157 | |
| 4 | 2021 | 78 | |
| 5 | 2011 | 62 | |
| 6 | 2021 | 61 | |
| 7 | 2013 | 57 | |
| 8 | 2009 | 51 | |
| 9 | 2020 | 51 | |
| 10 | 2001 | 48 | |
| 11 | 2020 | 44 | |
| 12 | 2017 | 43 | |
| 13 | 2021 | 42 | |
| 14 | 2013 | 41 | |
| 15 | 2009 | 40 | |
| 16 | 2014 | 39 | |
| 17 | 2021 | 36 | |
| 18 | 2021 | 34 | |
| 19 | 2019 | 33 | |
| 20 | 2017 | 32 |
About Haiyan Yang
Haiyan Yang is a scholar working on Molecular Biology, Infectious Diseases, Cardiology and Cardiovascular Medicine, Oncology and Epidemiology, having authored 221 papers that have together received 4.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (33 papers), Viral Infections and Immunology Research (24 papers), Long-Term Effects of COVID-19 (19 papers), Escherichia coli research studies (15 papers), CRISPR and Genetic Engineering (15 papers), Antibiotic Resistance in Bacteria (13 papers), COVID-19 and healthcare impacts (13 papers) and Antimicrobial Resistance in Staphylococcus (13 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Molecular Medicine (214 citations), Neurology (441 citations), Modeling and Simulation (133 citations) and Endocrinology (132 citations). Haiyan Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guangcai Duan, Shuaiyin Chen, Yuefei Jin, Wangquan Ji, Weidong Wu, William Zhang, Yadong Wang, Guangcai Duan, Weiguo Zhang and Jie Xu. Their work appears in journals such as Frontiers in Microbiology, Scientific Reports, Antimicrobial Agents and Chemotherapy, Oncotarget and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.